Health + Behavior

Dr. Alice Kuo and Dr. Angelica Zen argue that gun safety is a relevant issue for children's doctors and, if discussed in appointments, could reduce the number of accidents and deaths involving children.

Inner peace and a flexible body may not be the most valuable benefits that yoga and meditation have to offer, suggests new research by a UCLA-led team of neuroscientists.

Mutations in mitochondrial DNA can cause devastating diseases that mainly affect tissues and cells with high-energy demands, like the brain and muscles.

The researchers chalk up Denmark’s success to many factors, including the country’s universal health care system and the availability of free treatment for all people who have been infected with HIV.

A UCLA study shows that the drug pembrolizumab also has fewer side effects than traditional treatments.

With decades of experience in helping people with psychosis regain their place in society, UCLA neuroscientist Michael Green and his team of 10 psychiatrists, psychologists and other neuroscientists will look for ways to help formerly homeless veterans make the same transition.

UCLA cardiologist and molecular geneticist Dr. Stephen Young is renowned for his work on understanding mechanisms for human disease.

The finding could be a cause for concern because many countries rely on the agency to help pay for vital health care services for people with the diseases.

A new UCLA study examining child health in the context of asset poverty indicates that household wealth is linked more closely to health disparity than income or education level.

A UCLA policy brief recommends that veterans’ mental health status be continuously monitored throughout their lives, not just when emergencies arise.

Combining workouts with traditional behavioral therapy helped people who were addicted to methamphetamine.

An earlier study had suggested that a class of drugs called anthracyclines might increase the risk for neuropsychological issues and cognitive difficulties.

The researchers discovered good news as well: An omega-3 fatty acid known as docosahexaenoic acid seems to reverse the harmful changes.

The campus community gathered Wednesday for an evening devoted primarily to sleep and heard sound advice about how to wake up refreshed and rejuvenated from a panel of experts.

Prescribing antibiotics to patients who don’t need them can create problems so how do we get doctors to change their behaviors? Start by remembering that doctors are human, so not always perfectly rational.

A study by UCLA researchers demonstrates other benefits, too, among states that expanded Medicaid coverage under the Affordable Care Act.

A new study traces how a largely unfamiliar pathogen led to a global epidemic that has linked the virus to fetal brain-development disorders and Guillain-Barre syndrome.

Eventually, doctors might be able to analyze the levels and types of patients’ intestinal bacteria and then prescribe probiotics to bolster the amount of bacteria with anti-inflammatory properties.

The device combines two components invented at UCLA: a photonic time stretch microscope and a deep learning computer program that identifies cancer cells with over 95 percent accuracy.

The new technique uses penny-sized microfluidic chips that are equipped with minuscule DNA “bar codes,” which are no bigger than a single cell.

Participants will have access to highly individualized, intensive treatment that draws on UCLA’s nationally recognized expertise in neurology, neurosurgery, psychiatry and integrative medicine.

Already a leader in the field, UCLA will collaborate with five of the nation’s other top cancer centers in the Parker Institute for Cancer Immunotherapy.

Researchers will develop and test mobile technology, big data analytics, screening technologies and medical robotics in order to address challenges in the way health care is delivered.

The research found that the phenomenon holds true around the world — and that when people hear two women laughing together, they are likely to assume the women are friends.

The new technique can accurately identify a person’s optimal drug and dose combinations throughout an entire course of treatment, without complex, time-consuming genetic analysis.